Parsortix™ Library
Publications: 13 peer-reviewed publications
For Research Use Only. Not for use in diagnostic procedures.
Detection of circulating tumour cell clusters in human glioblastoma
Cancer Metastasis Laboratory, University of Basel and collaborators published by British Journal of Cancer, August 2018
The Parsortix™ Cell Separation System – A Versatile Liquid Biopsy Platform
ANGLE plc published by Cytometry Part A, Journal of Quantitative Cell Science, July 2018
Department of Cellular Pathology, Musgrove Park Hospital, Taunton UK published by the Journal of Clinical Pathology, March 2018
Challenges in using liquid biopsies for gene expression profiling
University of Southern California Norris Comprehensive Cancer Center published by Oncotarget, January 2018
University Medical Centre Hamburg-Eppendorf, Medical University of Graz and Stockholm University published by Clinical Chemistry, January 2018
Medical University of Vienna published by Oncotarget, November 2017
Comparison of isolation platforms for detection of circulating renal cell carcinoma cells
Clinic for Urology, University Hospital Muenster, Muenster, Germany published by Oncotarget, September 2017
Heinrich Heine University of Dusseldorf published by International Journal of Molecular Sciences, August 2017
Barts Cancer Institute published by Clinical Cancer Research, June 2017
University Medical Centre Hamburg-Eppendorf (UKE) published by Clinical Chemistry, September 2016
University Medical Centre Hamburg-Eppendorf (UKE) published by International Journal of Cancer, January 2016
Cancer Research UK Manchester Institute and Christie NHS Foundation Trust, Manchester UK published by Royal Society of Chemistry Analyst publication, November 2015
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System
Barts Cancer Institute, published by PLOS ONE on 23 September 2015
Posters: 22 publicly available posters
For Research Use Only. Not for use in diagnostic procedures.
ANGLE plc and QIAGEN GmbH as presented at the 11th International Symposium on Minimal Residual Cancer in Montpellier, France, May 2018 (ISMRC 2018)
Robert H Lurie Comprehensive Cancer Center and the Feinberg School of Medicine, Northwestern University, Chicago as presented at AACR 2018 in Chicago, April 2018
Bayer AG, Pharmaceutical Division as presented at AACR 2018 in Chicago, April 2018
University of Southern California Norris Comprehensive Cancer Center as presented at the San Antonio Breast Cancer Symposium in Texas, December 2017
ANGLE plc as presented at the AACC Emerging Clinical & Laboratory Diagnostics in the Healthcare Ecosystem (ECLD) conference in San Diego, November 2017
Universityclinic Tuebingen, Germany as presented at the Third International Advances in Circulating Tumour Cells (ACTC) Symposium in Rhodes, October 2017
Parsortix system enables isolation of viable CTCs from leukapheresis product with subsequent culture
Heinrich-Heine University Duesseldorf, Germany as presented at the Third International Advances in Circulating Tumour Cells (ACTC) Symposium in Rhodes, October 2017
Barts Cancer Institute, Queen Mary University of London as presented at the Third International Advances in Circulating Tumour Cells (ACTC) Symposium in Rhodes, October 2017
Single CTC isolation for genetic analysis using Parsortix and VyCAP
VyCAP B.V. as presented at the Third International Advances in Circulating Tumour Cells (ACTC) Symposium in Rhodes, October 2017
MD Anderson as presented at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia, August 2016 (AACC 2016)
Fraunhofer ITEM as presented at the 24th Biennial Congress of the European Association for Cancer Research, July 2016 (EACR 2016)
A highly sensitive method for circulating tumor cell antigen quantification in liquid biopsy
ANGLE Research & Development Laboratory as presented at the 24th Biennial Congress of the European Association for Cancer Research, July 2016 (EACR 2016)
Cancer Research UK Manchester Institute as presented at the American Association for Cancer Research Annual Meeting 2016, April 2016
Heinrich-Heine University, Düsseldorf, Germany as presented at the 10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, March 2016
Cancer Research UK Manchester Institute, as presented at the 10th ISMRC International Symposium on Minimal Residual
Integration of RNA and DNA blood-borne cancer biomarkers
Cancer Research UK Manchester Institute, as presented at the 10th ISMRC International Symposium on Minimal Residual
Circulating rare cells enable highly efficient cancer detection
Medical University of Vienna, as presented at 18th ECCO – 40th ESMO European Cancer Congress September 2015
Intra-tumor heterogeneity in prostate cancer and the implication in CTC analysis
Barts Cancer Institute, as presented at a symposium hosted by the British Association for Cancer Research and Cancer Research UK on 11 June 2015
Circulating rare cells enable highly efficient cancer detection
Medical University of Vienna, as presented at the AACR conference April 2015
Enrichment and isolation of uncontaminated breast cancer cells from human blood samples
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, as presented at the AACR conference April 2015
CRUK – Manchester, as presented at NCRI conference November 2014
Technical validation of a novel label-independent device to capture CTCs
The University Medical Center Hamburg-Eppendorf (UKE), as presented at ACTC Conference, October 2014
Whitepapers
For Research Use Only. Not for use in diagnostic procedures.
Parsortix Small Volume Capabilities
Parsortix™ Cell Separation System Small Volume Capabilities
Presentation
Presentation to the Sixth International Molecular Diagnostics Europe conference on 24 May 2018